LT3360575T - Transderminės farmacinės kompozicijos, apimančios veiksminguosius agentus - Google Patents
Transderminės farmacinės kompozicijos, apimančios veiksminguosius agentusInfo
- Publication number
- LT3360575T LT3360575T LTEP18163659.8T LT18163659T LT3360575T LT 3360575 T LT3360575 T LT 3360575T LT 18163659 T LT18163659 T LT 18163659T LT 3360575 T LT3360575 T LT 3360575T
- Authority
- LT
- Lithuania
- Prior art keywords
- pharmaceutical compositions
- active agents
- transdermal pharmaceutical
- transdermal
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25524109P | 2009-10-27 | 2009-10-27 | |
| EP09178762 | 2009-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3360575T true LT3360575T (lt) | 2023-06-12 |
Family
ID=42102488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP18163659.8T LT3360575T (lt) | 2009-10-27 | 2010-10-27 | Transderminės farmacinės kompozicijos, apimančios veiksminguosius agentus |
| LTEP10768983.8T LT2493508T (lt) | 2009-10-27 | 2010-10-27 | Transderminės farmacinės kompozicijos, apimančios aktyviuosius agentus |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP10768983.8T LT2493508T (lt) | 2009-10-27 | 2010-10-27 | Transderminės farmacinės kompozicijos, apimančios aktyviuosius agentus |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US10080760B2 (lt) |
| EP (2) | EP3360575B1 (lt) |
| JP (1) | JP5727494B2 (lt) |
| CN (1) | CN102686240B (lt) |
| AU (1) | AU2010311523B2 (lt) |
| BR (1) | BR112012010083B8 (lt) |
| CA (1) | CA2778689C (lt) |
| CY (1) | CY1120888T1 (lt) |
| DK (2) | DK2493508T3 (lt) |
| ES (2) | ES2685313T3 (lt) |
| FI (1) | FI3360575T3 (lt) |
| HR (2) | HRP20230482T1 (lt) |
| HU (2) | HUE039200T2 (lt) |
| IL (1) | IL219236A (lt) |
| LT (2) | LT3360575T (lt) |
| PL (2) | PL2493508T3 (lt) |
| PT (2) | PT3360575T (lt) |
| RS (2) | RS64190B1 (lt) |
| RU (2) | RU2639087C2 (lt) |
| SI (2) | SI3360575T1 (lt) |
| TR (1) | TR201811600T4 (lt) |
| WO (1) | WO2011051354A2 (lt) |
| ZA (1) | ZA201202855B (lt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2147674A1 (en) * | 2008-07-24 | 2010-01-27 | Besins Healthcare | Transdermal pharmaceutical compositions comprising danazol |
| US10080760B2 (en) | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
| US20120004204A1 (en) * | 2010-07-02 | 2012-01-05 | Biosante Pharmaceuticals, Inc. | Methods for treating sexual dysfunction while decreasing cardiovascular risk |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| HUE055562T2 (hu) | 2011-11-23 | 2021-11-29 | Therapeuticsmd Inc | Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| RU2592370C9 (ru) * | 2014-04-24 | 2016-08-27 | Иван Иванович Дедов | Средство на основе дегидроэпиандростерона, способ его применения |
| RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
| WO2016018993A1 (en) | 2014-07-29 | 2016-02-04 | Therapeuticsmd, Inc. | Transdermal cream |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
| EP3370178A3 (en) | 2017-03-03 | 2018-12-19 | Tata Consultancy Services Limited | Method and system for in silico testing of actives on human skin |
| RU2751037C1 (ru) * | 2020-04-03 | 2021-07-07 | Богдан Иванович Асатуров | Фармацевтическая композиция на основе аутобиокомпонентов мочи человека для трансдермального применения с лечебной или косметической целью |
| CN111803469B (zh) * | 2020-07-15 | 2022-08-12 | 浙江海阁堂医药有限公司 | 一种含雌二醇透皮吸收缓释贴片及其制备方法 |
| CN113730339B (zh) * | 2021-09-17 | 2023-08-22 | 中国药科大学 | 一种黄体酮缓释组合物及其应用 |
| EP4308088A4 (en) * | 2021-11-08 | 2024-06-12 | Weiyong Li | TRANSDERMAL DRUG DELIVERY SYSTEM FOR DELIVERING DRUG TO A PATIENT |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1106455B (de) | 1959-05-29 | 1961-05-10 | Upjohn Co | Salbengrundlage |
| FR2518879A1 (fr) | 1981-12-30 | 1983-07-01 | Besins Jean | Medicament a base d'oestradiol pour le traitement de la pathologie menopausique |
| US4906169A (en) | 1986-12-29 | 1990-03-06 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
| JPH0798935B2 (ja) | 1987-11-25 | 1995-10-25 | 有限会社野々川商事 | 品質劣化防止剤 |
| EP0364211B1 (en) | 1988-10-11 | 1994-12-21 | Shire Holdings Ltd. | A percutaneous pharmaceutical preparation |
| US5332577A (en) | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| EP0409383B1 (en) * | 1989-07-21 | 1994-04-06 | Izhak Blank | Estradiol compositions and methods for topical applications |
| US5232703A (en) | 1989-07-21 | 1993-08-03 | Izhak Blank | Estradiol compositions and methods for topical application |
| MX9101787A (es) | 1990-10-29 | 1992-06-05 | Alza Corp | Formulaciones,metodos y dispositivos anticonceptivos transdermicos |
| DE4227989A1 (de) | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
| CA2176824A1 (en) | 1993-12-27 | 1995-07-06 | Hiroshi Kuroda | Percutaneously absorbable preparation |
| CN1106259A (zh) | 1994-02-05 | 1995-08-09 | 日东制药株式会社 | 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂 |
| FR2732223B1 (fr) * | 1995-03-30 | 1997-06-13 | Sanofi Sa | Composition pharmaceutique pour administration transdermique |
| US5902603A (en) * | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
| JP3081531B2 (ja) | 1996-03-22 | 2000-08-28 | 株式会社ヱビス科学研究所 | 手投げ消火液弾 |
| US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
| IT1283102B1 (it) | 1996-06-06 | 1998-04-07 | Permatec Nv | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele |
| RU2122396C1 (ru) | 1996-07-12 | 1998-11-27 | Валентина Александровна Андрюшина | Биологически-активная добавка в косметические изделия |
| AU718811B2 (en) | 1996-10-30 | 2000-04-20 | Theratech, Inc. | Fatty acid esters of glycolic acid and its salts as permeation enhancers |
| KR100215027B1 (ko) | 1997-01-27 | 1999-08-16 | 성재갑 | 스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형 |
| DK1510213T3 (da) | 1997-11-10 | 2009-03-23 | Strakan Int Ltd | Penetrationsforbedrende og irritationsreducerende systemer omfattende testosteron |
| EP1043020A1 (en) | 1997-12-25 | 2000-10-11 | Daiichi Pharmaceutical Co., Ltd. | Medicinal composition for percutaneous administration |
| US6582724B2 (en) | 1999-12-16 | 2003-06-24 | Dermatrends, Inc. | Dual enhancer composition for topical and transdermal drug delivery |
| KR100856523B1 (ko) | 2000-08-03 | 2008-09-04 | 안타레스 파르마 아이피엘 에이쥐 | 충분한 치료효과를 보장하는 활성 화합물의 경피 및/또는경점막 투여용 신규 조성물 |
| KR100416646B1 (ko) | 2000-08-14 | 2004-02-05 | 구주제약주식회사 | 리도카인을 함유한 조루치료용 마이크로에멀젼 하이드로겔 제형의 약학 조성물 |
| US20040002482A1 (en) | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| FR2814074B1 (fr) | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
| JP2002212105A (ja) | 2001-01-22 | 2002-07-31 | Lion Corp | 水性皮膚外用剤組成物 |
| AU2002340120A1 (en) | 2001-10-04 | 2003-04-14 | Cellegy Pharmaceuticals, Inc. | Semisolid topical hormonal compositions and methods for treatment |
| US20040072810A1 (en) | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| HU230920B1 (hu) * | 2002-03-15 | 2019-03-28 | Besins Healthcare Luxembourg Sarl | Depresszió kezelésére szolgáló androgén gyógyászati készítmények |
| US6756050B2 (en) | 2002-06-28 | 2004-06-29 | Ultra Biotech Limited | Dietary supplements for improving memory |
| FR2848112B1 (fr) | 2002-12-10 | 2007-02-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations |
| FR2851470B1 (fr) | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
| EP1608353B1 (en) | 2003-04-01 | 2014-04-30 | Besins Healthcare Luxembourg SARL | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| US20070196325A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for dermally treating infections |
| EP1634583A1 (en) | 2004-09-09 | 2006-03-15 | Laboratoires Besins International | Testosterone gels comprising propylene glycol as penetration enhancer |
| EP1647271A1 (en) | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
| AU2005293712B2 (en) * | 2004-10-14 | 2011-04-21 | Besins Healthcare Luxembourg Sarl | 4-hydroxy tamoxifen gel formulations |
| US20070082039A1 (en) | 2004-10-18 | 2007-04-12 | Jones Gerald S Jr | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids |
| CA2604400A1 (en) | 2005-04-12 | 2006-10-19 | Unimed Pharmaceuticals, Inc. | Method of treating or preventing bone deterioration or osteoporosis |
| KR20110108426A (ko) | 2005-04-25 | 2011-10-05 | 다우 파마슈티컬 사이언시즈 | 건선 치료를 위한 클로베타솔 분무 제형의 용도 |
| WO2007038496A2 (en) * | 2005-09-27 | 2007-04-05 | Chemic Laboratories, Inc. | Synthesis of fatty alcohol esters of hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers |
| EP2147674A1 (en) | 2008-07-24 | 2010-01-27 | Besins Healthcare | Transdermal pharmaceutical compositions comprising danazol |
| EP3202420B1 (en) | 2008-12-11 | 2020-03-04 | Besins Healthcare Luxembourg SARL | Transdermal pharmaceutical compositions comprising a serm |
| US10080760B2 (en) | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
-
2010
- 2010-10-26 US US12/912,310 patent/US10080760B2/en active Active
- 2010-10-27 RS RS20230352A patent/RS64190B1/sr unknown
- 2010-10-27 BR BR112012010083A patent/BR112012010083B8/pt active IP Right Grant
- 2010-10-27 ES ES10768983.8T patent/ES2685313T3/es active Active
- 2010-10-27 AU AU2010311523A patent/AU2010311523B2/en active Active
- 2010-10-27 RU RU2012121708A patent/RU2639087C2/ru active
- 2010-10-27 LT LTEP18163659.8T patent/LT3360575T/lt unknown
- 2010-10-27 WO PCT/EP2010/066283 patent/WO2011051354A2/en active Application Filing
- 2010-10-27 HU HUE10768983A patent/HUE039200T2/hu unknown
- 2010-10-27 ES ES18163659T patent/ES2945590T3/es active Active
- 2010-10-27 HR HRP20230482TT patent/HRP20230482T1/hr unknown
- 2010-10-27 RS RS20180963A patent/RS57596B1/sr unknown
- 2010-10-27 DK DK10768983.8T patent/DK2493508T3/en active
- 2010-10-27 PT PT181636598T patent/PT3360575T/pt unknown
- 2010-10-27 EP EP18163659.8A patent/EP3360575B1/en active Active
- 2010-10-27 LT LTEP10768983.8T patent/LT2493508T/lt unknown
- 2010-10-27 TR TR2018/11600T patent/TR201811600T4/tr unknown
- 2010-10-27 DK DK18163659.8T patent/DK3360575T3/da active
- 2010-10-27 SI SI201032129T patent/SI3360575T1/sl unknown
- 2010-10-27 RU RU2017131709A patent/RU2017131709A/ru unknown
- 2010-10-27 CA CA2778689A patent/CA2778689C/en active Active
- 2010-10-27 FI FIEP18163659.8T patent/FI3360575T3/fi active
- 2010-10-27 CN CN201080059696.5A patent/CN102686240B/zh active Active
- 2010-10-27 JP JP2012535814A patent/JP5727494B2/ja active Active
- 2010-10-27 SI SI201031737T patent/SI2493508T1/sl unknown
- 2010-10-27 PL PL10768983T patent/PL2493508T3/pl unknown
- 2010-10-27 EP EP10768983.8A patent/EP2493508B1/en active Active
- 2010-10-27 HU HUE18163659A patent/HUE062026T2/hu unknown
- 2010-10-27 PL PL18163659.8T patent/PL3360575T3/pl unknown
- 2010-10-27 PT PT10768983T patent/PT2493508T/pt unknown
-
2012
- 2012-04-17 IL IL219236A patent/IL219236A/en active IP Right Grant
- 2012-04-18 ZA ZA2012/02855A patent/ZA201202855B/en unknown
-
2018
- 2018-08-13 CY CY181100850T patent/CY1120888T1/el unknown
- 2018-08-23 US US16/111,098 patent/US11040043B2/en active Active
- 2018-08-23 HR HRP20181346TT patent/HRP20181346T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181346T1 (hr) | Transdermalni farmaceutski pripravci koji sadrže aktivne tvari | |
| HRP20180924T1 (hr) | Sastavi za transdermalnu administraciju aktivnih sastojaka | |
| HK1169960A1 (en) | Pharmaceutical formulation | |
| HU0900072D0 (en) | Transdermal pharmaceutical compositions | |
| HK1199217A1 (en) | Topical pharmaceutical composition including active agents | |
| EP2468771A4 (en) | PHARMACEUTICAL COMPOSITION WITH AN ANTIBODY TO HB-EGF AS AN ACTIVE SUBSTANCE | |
| EP2465512A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING PAIN | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| EP2514440A4 (en) | TRANSDERMAL PREPARATION WITH A BASIC INFLAMMATORY MEDIUM | |
| IL226237A0 (en) | Pharmaceutical preparations for administration through the skin | |
| GB0903945D0 (en) | Pharmaceutical compounds and compositions | |
| GB0919055D0 (en) | Pharmaceutical compounds and compositions | |
| GB0908069D0 (en) | Pharmaceutical compounds and compositions | |
| GB0902651D0 (en) | Pharmaceutical compounds and compositions | |
| GB0905555D0 (en) | Pharmaceutical agent | |
| GB0905557D0 (en) | Pharmaceutical agent | |
| GB0905558D0 (en) | Pharmaceutical agent | |
| GB0910754D0 (en) | Pharmaceutical agent | |
| GB0913956D0 (en) | Pharmaceutical agent | |
| GB0920790D0 (en) | Pharmaceutical agent | |
| GB0918912D0 (en) | Improved medicament formulation |